Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,135,mmHg,3.0,7.3485,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 1 week,,,,control condition and light phase of controlled light/dark cycle (for 12 hours),103524,control condition,light phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,5,,CMO:0000004,systolic blood pressure,,daytime measurement,,134,mmHg,4.0,8.9443,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 1 week,,,,control condition and light phase of controlled light/dark cycle (for 12 hours),103525,control condition,light phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,6,,CMO:0000004,systolic blood pressure,,daytime measurement,,145,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 4 weeks,,,,vehicle control condition (for 28 days) and light phase of controlled light/dark cycle (for 12 hours),103528,vehicle control condition (for 28 days),light phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,5,,CMO:0000004,systolic blood pressure,,daytime measurement,,139,mmHg,3.0,6.7082,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/day for 4 weeks,,,,salidroside (40 mg/kg) (for 28 days) and light phase of controlled light/dark cycle (for 12 hours),103529,salidroside (40 mg/kg) (for 28 days),light phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,143,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,measured 12 hr/night for 1 week,,,,control condition and dark phase of controlled light/dark cycle (for 12 hours),103532,control condition,dark phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,140 days to 133 days,5,,CMO:0000004,systolic blood pressure,,nighttime measurement,,143,mmHg,4.0,8.9443,MMO:0000070,intra-aortic abdominal radiotelemetry,,0.0,measured 12 hr/night for 1 week,,,,control condition and dark phase of controlled light/dark cycle (for 12 hours),103533,control condition,dark phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,6,,CMO:0000004,systolic blood pressure,,nighttime measurement,,145,mmHg,4.0,9.798,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/night for 4 weeks,,,,vehicle control condition (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours),103536,vehicle control condition (for 28 days),dark phase of controlled light/dark cycle (for 12 hours) 2827,"Alameddine A, et al., J Physiol Pharmacol. 2015 Apr;66(2):249-57.",arterial blood pressure trait,,RS:0001299,GK,male,168 days,5,,CMO:0000004,systolic blood pressure,,nighttime measurement,,146,mmHg,3.0,6.7082,MMO:0000070,intra-aortic abdominal radiotelemetry,,,measured 12 hr/night for 4 weeks,,,,salidroside (40 mg/kg) (for 28 days) and dark phase of controlled light/dark cycle (for 12 hours),103537,salidroside (40 mg/kg) (for 28 days),dark phase of controlled light/dark cycle (for 12 hours)